These benefits include increased drug solubility, enhanced drug distribution within tumor tissues, minimized cytotoxicity, the capacity to traverse biological barriers, and the potential for combined drug applications.[2] Crucially, the efficacy and specificity of drug delivery can be amplified by attaching NDDS to tumor‐specific cell surface receptors. The gene discussed is CD177; the disease is neoplasm.